
Trials advance for fewer injections
Intravitreal (IVT) reservoirs for the sustained treatment of wet age-related macular degeneration (AMD), diabetic macular oedema (DMO), retinal vein occlusion (RVO) and uveitis have achieved promising results in several trials.










